Aberrant gene promoter methylation in acute promyelocytic leukaemia: Profile and prognostic significance

British Journal of Haematology

Volumn 122, Issue 4, 2003, Pages 571-578

  Chim, Chor S ^a   Wong, Seung Y ^a   Kwong, Yok L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Aberrant methylation; APL; Prognosis

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 8; CYTARABINE; DAUNORUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; PROTEIN P15; PROTEIN P16; PROTEIN P73; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; UVOMORULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DNA METHYLATION; FEMALE; HUMAN; MALE; MYELOID LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); SEQUENCE ALIGNMENT; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0043163772     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04462.x     Document Type: Article

References (35)

1. Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K., Oh, H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikawa, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Erni, N. & Ohno, R. (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Journal of Clinical Oncology, 16, 78-85.
2. Au, W.Y., Chim, C.S., Lie, A.K., Liang, R. & Kwong, Y.L. (2002) Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide. British Journal of Haematology, 117, 130-132.
3. Baylin, S.B. & Herman, J.G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends in Genetics, 16, 168-174.
4. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. & Issa, J.P. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Advances in Cancer Research, 72, 141-196.
5. Branch, H., Weirich, G., Brieger, J., Glavac, D., Rodl, H., Eichinger, M., Feurer, M., Weidt, E., Puranakanitstha, C., Neuhaus, C., Pomer, S., Brenner, W., Schirmacher, P., Storkel, S., Rotter, M., Masera, A., Gugeler, N. & Decker, H.J. (2000) VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Research, 60, 1942-1948.
6. Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P.G., Atwater, S. & Bishop, J.M. (1997) A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 94, 2551-2556.
7. Chim, C.S., Kwong, Y.L., Liang, R., Chu, Y.C., Chan, C.H., Chan, L.C., Wang, K.F. & Chan, T.K. (1996) All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL). Hematological Oncology, 14, 147-154.
8. Chim, C.S., Liang, R., Tam, C. & Kwong, Y.L. (2001a) P15 and p16 promoter methylation in acute promyelocytic leukemia. Journal of Clinical Oncology, 19, 2033-2040.
9. Chim, C.S., Tam, C., Liang, R. & Kwong, Y.L. (2001b) P15 and p16 gene methylation in adult acute leukemia: lack of prognostic significance. Cancer, 91, 2222-2229.
10. Chim, C.S., Liang, R. & Kwong, Y.L. (2002) Gene promoter hypermethylation in hematologic malignancies. Hematological Oncology. 20, 167-176.
11. Corn, P.G., Smith, B.D., Ruckdeschel, E.S., Douglas, D., Baylin, S.B. & Herman, J.G. (2000) E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia. Clinical Cancer Research, 6, 4243-4248.
12. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C., Schuller, D.E., Yu, L., Bloomfield, C.D., Caligiuri, M.A., Yates, A., Nishikawa, R., Su, Huang, H., Petrelli, N.J., Zhang, X., O'Dorisio, M.S., Held, W.A., Cavenee, W.K. & Plass, C. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genetics, 24, 132-138.
13. Cox, D.R. (1972) Regression models and life-tables. Journal of the Royal Society of Statistics, Series B, 34, 187-220.
14. De The, H., Chomienne, C., Lanotte, M., Degos, L. & Dijean, A. (1990) The t(15:17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature, 347, 558.
15. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., Minucci, S. & Pelicci, P.G. (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science, 295, 1079-1082.
16. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S.N., Hidalgo, O.F., Vanaclocha, V., Baylin, S.B. & Herman, J.G. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. New England Journal of Medicine, 343, 1350-1354.
17. Esteller, M., Corn, P.G., Baylin, S.B. & Herman, J.G. (2001) A gene hypermethylation profile of human cancers. Cancer Research, 61, 3225-3229.
18. He, L.Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P.G., Soares, V., Cattoretti, G. & Pandolfi, P.P. (1997) Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 94, 5302-5307.
19. Issa, J.P., Vertino, P.M., Wu, J., Sazawal, S., Celano, P., Nelkin, B.D., Hamilton, S.R. & Baylin, S.B. (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. Journal of the National Cancer Institute, 85, 1235-1240.
20. Issa, J.P., Baylin, S.B. & Herman, J.G. (1997) DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia, 11, s7-s11.
21. Kakizuka, A., Miller, Jr, W.H., Umesono, K., Warrell, Jr, R.P., Frankel, S.R., Murty, V.V., Dmitrovsky, E. & Evans, R.M. (1991) Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell, 66, 663.
22. Kwong, Y.L., Au, W.Y., Chim, C.S., Pang, A., Suen, C. & Liang, R. (2001) Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study. American Journal of Hematology, 66, 274-279.
23. Leonhardt, H. & Cardoso, M.C. (2000) DNA methylation, nuclear structure, gene expression and cancer. Journal of Cell Biochemistry, 35, s78-s83.
24. Melki, J.R., Vincent, P.C. & Clark, S.J. (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Research, 59, 3730-3740.
25. Melki, J.R., Vincent, P.C., Brown, R.D. & Clark, S.J. (2000) Hypermethylation of E-cadherin in leukemia, Blood, 95, 3208-3213.
26. Mizuno, S., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y. & Sasaki, H. (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood, 97, 1172-1179.
27. Robertson. K.D. & Wolffe, A.P. (2000) DNA methylation in health and disease. Nature Reviews Genetics, 1, 11-19.
28. Sanz, M.A., Lo Coco, F., Martin, G., Avvisati, G., Rayon, C., Barbui, T., Diaz-Mediavilla, J., Fioritoni, G., Gonzalez, J.D., Liso. V., Esteve, J.. Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. & Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 1247-1253.
29. Singal, R. & Ginder, G.D. (1999) DNA methylation. Blood, 93, 4059-4070.
30. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 1021-1028.
31. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Woods, W.G., Ogden, A., Weinstein, H., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood, 100, 4298-4302.
32. Teitz, T., Wei, T., Valentine, M.B., Vanin, E.F., Grenet, J., Valentine, V.A., Behm, F.G., Look, A.T., Lahti, J.M. & Kidd, V.J. (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nature Medicine. 6, 529-535.
33. Toyota, M., Kopecky, K.J., Toyota, M.O., Jair, K.W., Willman, C.L. & Issa, J.P. (2001) Methylation profiling in acute myeloid leukemia. Blood, 97, 2823-2829.
34. Warrell, Jr, R.P., De The, H., Wang, Z.Y. & Degos, L. (1993) Acute promyelocytic leukemia. New England Journal of Medicine, 329, 177-189.
35. Wong, I.H.N., Ng, M.H.L., Huang, D.P. & Lee, J.C.K. (2000) Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood, 95, 1942-1949.